Nitrase Therapeutics showed suppressing the activity of an enzyme called synuclein nitrase reduces toxic clumps of the alpha-synuclein protein…
Articles by Andrea Lobo
Being exposed to insecticides impacts gastrointestinal function and might increase the risk of developing Parkinson’s disease, a new study…
The U.S. Food and Drug Administration (FDA) will review Amneal Pharmaceuticals’ application for IPX203, its extended-release carbidopa/levodopa (CD/LD) tablet…
MindMaze is partnering with Mount Sinai Health System in New York to accelerate the access of people with…
Aggression aimed at caregivers in Parkinson’s disease and related disorders is associated with patients’ grief in coping with disease…
Treatment with DopaFuse, a continuous oral levodopa-carbidopa delivery system being developed by SynAgile, was safe and lessened motor…
Dental care often is irregular in people with Parkinson’s disease, who also require more dental treatments that those without…
People who had COVID-19 might have an increased risk for developing neurodegenerative diseases, such as Parkinson’s disease, researchers in…
Neural implants combining artificial intelligence with microelectronics could directly modulate the brain’s activity to help treat brain disorders, including…
New York University Langone Health is collaborating with the Michael J. Fox Foundation for Parkinson’s Research in the Parkinson’s…